WT1 and cancer: By stimulating WT1-specific cytotoxic and helper T cells, DSP-7888 in combination with anti-programmed cell death protein 1 (PD-1) demonstrated its ability to elicit strong antitumoral activity toward cancer cells expressing high levels of WT1 during in vitro and in vivo preclinical trials.